UiPath/$PATH
1D1W1MYTD1Y5YMAX
Capital at risk
About UiPath
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.
- Ticker
- $PATH
- Sector
- Software & Cloud Services
- Primary listing
- NYSE
- Employees
- 3,981
- Headquarters
- New York, United States
- Website
- www.uipath.com
UiPath Metrics
BasicAdvanced
$7.1B
20.15
$0.68
1.02
-
Price and volume
Market cap
$7.1B
Beta
1.02
52-week high
$19.84
52-week low
$9.20
Average daily volume
67M
Financial strength
Current ratio
2.387
Quick ratio
2.139
Long term debt to equity
0.036
Total debt to equity
0.041
Profitability
EBITDA (TTM)
184.894
Gross margin (TTM)
82.58%
Net profit margin (TTM)
21.03%
Operating margin (TTM)
9.38%
Effective tax rate (TTM)
-71.64%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
3.67%
Return on equity (TTM)
20.03%
Valuation
Price to earnings (TTM)
20.153
Price to revenue (TTM)
4.181
Price to book
3.64
Price to tangible book (TTM)
4.25
Price to free cash flow (TTM)
19.821
Free cash flow yield (TTM)
5.05%
Free cash flow per share (TTM)
0.688
Growth
Revenue change (TTM)
14.98%
Earnings per share change (TTM)
1,732.84%
3-year revenue growth (CAGR)
14.44%
3-year earnings per share growth (CAGR)
28.41%
What the Analysts think about UiPath
Analyst ratings (Buy, Hold, Sell) for UiPath stock.
Analyst projections of the future price of UiPath stock.
Bulls say / Bears say
Q2 revenue of $410.3 million beat consensus of $397.8 million and grew 13% YoY, demonstrating robust platform adoption. (Reuters)
Raised Q3 FY 2027 revenue guidance to $440 million–$445 million, with the midpoint above analyst estimates, signaling management confidence in sustained demand momentum. (Reuters)
Achieved non-GAAP operating income of $89 million and GAAP operating income of $32 million in Q2 FY 2027, reflecting improved profitability and operating leverage. (Reuters)
YoY revenue growth decelerated from 17% in Q1 FY 2027 to 13% in Q2 FY 2027, suggesting a slowdown in core demand. (8-K Q1 FY 2027 Results, 8-K Q2 FY 2027 Results)
Net new ARR declined to $37 million in Q2 FY 2027 from $49 million in Q1 FY 2027, indicating weaker customer expansion momentum. (8-K Q1 FY 2027 Results, 8-K Q2 FY 2027 Results)
Net cash flow from operations plunged from $132 million in Q1 FY 2027 to $31 million in Q2 FY 2027, pointing to cash conversion headwinds and potential working capital strain. (8-K Q1 FY 2027 Results, 8-K Q2 FY 2027 Results)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2026.
UiPath Financial Performance
Revenues and expenses
UiPath Earnings Performance
Company profitability
Upcoming events
No upcoming events
UiPath News
AllArticlesVideos

UiPath Targets AI-Powered Growth Reacceleration as ARR Hits $1.94B
MarketBeat4 days ago

UiPath Powers PLDT's AI Transformation to Enhance Customer Service and Operational Efficiency Amid Surging Demand for Digital Connectivity
Business Wire6 days ago

Stuck in Agentic AI Pilot Purgatory? UiPath Survey Points to Orchestration as Key to Scaling Enterprise Deployments
Business Wire1 week ago
Funds containing UiPath
AllEURGBPUSD
Fund name | Fund size | $PATH weighting |
|---|---|---|
WisdomTree Artificial Intelligence€WTAI | €996M | 1.55% |
WisdomTree Artificial Intelligence£INTL | £870M | 1.55% |
iShares Automation & Robotics$RBOT | $5.2B | 0.30% |
iShares Automation & Robotics€2B76 | €4.5B | 0.30% |
iShares Automation & Robotics£RBTX | £3.8B | 0.30% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.